.png)
ProteusDx™ by FirstVitals® Business Summary
FirstVitals® is redefining the future of gastrointestinal diagnostics (GI) with a bold, Artifical Intelligence first approach to Video Capsule Endoscopy (VCE)-and we’re not just leading the market, we’re expanding it.
As the first mover to bring AI-powered VCE across humans, companion pets, and large animals, FirstVitals® is unlocking an entirely new frontier of multi-species diagnostics. Our proprietary platform combines wireless capsule endoscopy with real-time AI interpretation with video capsule endoscopy to enable non-invasive, accurate, and scalable GI imaging, revolutionizing early disease detection.
In human healthcare, our AI-driven platform enhances accuracy, reduces bottlenecks in GI care, and increases accessibility-especially for rural and underserved populations. But we don't stop there, we go further... our patented veterinary solution brings the same AI innovation to dogs, cats, and elite performance horses, addressing an urgent diagnostic need in a high-margin, underserved markets with little to no direct competition.
Investors have a rare window to be part of this paradigm shift. With a platform that bridges human and veterinary medicine, a rapidly expanding TAM, and proprietary IP in both AI and capsule technology, FirstVitals® is positioned to dominate a new category of precision diagnostics.
The race to lead AI in GI imaging has already started. Will you be part of the company that’s shaping it-or watch from the sidelines?
Human Health
The human gastrointestinal market faces bottlenecks: limited specialists, delayed endoscopies, and costly procedures. ProteusDx™ transforms GI diagnostics with an FDA-cleared capsule platform enhanced by AI, offering accurate detection of GERD, ulcers, and other GI conditions without sedation or scoping.
We're not just improving diagnostics-we’re enabling earlier treatment, better outcomes, and reduced costs. As healthcare shifts toward outpatient and remote models, ProteusDx™ empowers clinics and health systems to meet rising demand for fast, scalable solutions.
Companion Pets
Veterinarians face challenges diagnosing GI issues in pets-traditional endoscopy is invasive, expensive, and often unavailable. ProteusDx™ provides a non-invasive, capsule-based solution tailored for dogs and cats, detecting ulcers, IBD, tumors, and motility issues with AI-driven image analysis.
This consumer-pay segment is ripe for disruption, with high spending tolerance among pet owners and virtually no direct competitors offering smart capsule diagnostics.
Equine
Up to 90% of performance horses suffer from gastric ulcers-yet traditional diagnosis is difficult, often skipped, and requires sedation and scoping. ProteusDx™ Equine introduces a safe, ingestible solution that detects ulcers, delivers localized treatment, and monitors healing-all without invasive procedures.
This gives trainers, breeders, and owners a revolutionary tool to optimize performance and wellness, all in a high-value, self-pay market with fast adoption cycles.
The human gastrointestinal market faces bottlenecks: limited specialists, delayed endoscopies, and costly procedures. ProteusDx™ transforms GI diagnostics with an FDA-cleared capsule platform enhanced by AI, offering accurate detection of GERD, ulcers, and other GI conditions without sedation or scoping.
We're not just improving diagnostics-we’re enabling earlier treatment, better outcomes, and reduced costs. As healthcare shifts toward outpatient and remote models, ProteusDx™ empowers clinics and health systems to meet rising demand for fast, scalable solutions.
Veterinarians face challenges diagnosing GI issues in pets-traditional endoscopy is invasive, expensive, and often unavailable. ProteusDx™ provides a non-invasive, capsule-based solution tailored for dogs and cats, detecting ulcers, IBD, tumors, and motility issues with AI-driven image analysis.
This consumer-pay segment is ripe for disruption, with high spending tolerance among pet owners and virtually no direct competitors offering smart capsule diagnostics.
Up to 90% of performance horses suffer from gastric ulcers-yet traditional diagnosis is difficult, often skipped, and requires sedation and scoping. ProteusDx™ Equine introduces a safe, ingestible solution that detects ulcers, delivers localized treatment, and monitors healing-all without invasive procedures.
This gives trainers, breeders, and owners a revolutionary tool to optimize performance and wellness, all in a high-value, self-pay market with fast adoption cycles.
Why Invest in FirstVitals®?
Non-invasive AI-powered Video Capsule Endoscopy (VCE) for both human and veterinary markets.
SaaS + Licensing strategy ensures recurring revenue streams.
FDA-cleared VCE with AI approval in progress.
$1.5B+ in human endoscopy, untapped veterinary GI market.
Proven demand from hospitals, healthcare providers, and veterinary networks.
Terms of the Offering
The minimum commitment for investors is 100 shares, priced at $8.50 per share, resulting in an initial investment of $850.
Product Development
Sales and Marketing
Operations and Infrastructure
Regulatory
Compliance and Legal
General and Administrative
Working Capital
Organization and
Offering Expenses
Leadership Team
%20(1).png)
Ernie Lee
Susan Kim van Dongen
Anthony Voorhies
Dr. Anastasia Katany
Gagan Singh
Why using Biotech
Lorem ipsum dolor sit amet consectetur quam risus adipiscing sodales sed diam maecenas volutpat purus at consequat.
Increase your productivity
Lorem ipsum dolor sit amet consectetur quam risus adipiscing sodales sed diam maecenas volutpat purus at consequat.
Get the best sleep ever
Volutpat ac sit aliquet ipsum viverra id magna egestas sit lacus volutpat interdum aliquet dui nibh scelerisque est felis nullam augue tincidunt sagittis.
Reach your fitness goals
Vitae sed fringilla dignissim interdum nibh commodo mauris egestas volutpat risus pellentesque ut cursus viverra duis scelerisque ac orci a elit mauris.
Connect all your devices
Lorem ipsum dolor sit amet consectetur quis euismod aenean laoreet varius ac non aenean accumsan fringilla vitae.
What our users say
Lorem ipsum dolor sit amet consectetur nunc dictumst viverra metus enim nec pellentesque rhoncus duis purus nibh sagittis nibh morbi vitae ac.
John Carter
Manhattan, NY
“A game-changer for health monitoring. It's intuitive and incredibly precise”
Urna aliquet sit morbi luctus amet dolor suspendisse mauris fames dignissim est turpis eu purus tellus ipsum quis turpis.
Sophie Moore
San Diego, CA
“A game-changer for health monitoring. It's intuitive and incredibly precise”
Urna aliquet sit morbi luctus amet dolor suspendisse mauris fames dignissim est turpis eu purus tellus ipsum quis turpis.
Matt Cannon
New York, NY
“A game-changer for health monitoring. It's intuitive and incredibly precise”
Urna aliquet sit morbi luctus amet dolor suspendisse mauris fames dignissim est turpis eu purus tellus ipsum quis turpis.
Andy Smith
San Francisco, CA
“A game-changer for health monitoring. It's intuitive and incredibly precise”
Urna aliquet sit morbi luctus amet dolor suspendisse mauris fames dignissim est turpis eu purus tellus ipsum quis turpis.
Blog & resources
Lorem ipsum dolor sit amet consectetur quam risus adipiscing sodales sed diam maecenas volutpat purus at consequat.
